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Abstract
Background:  During systemic gram-negative bacterial infections, lipopolysaccharide
(LPS) ligation to the hepatic Toll-like receptor-4 complex induces the production of
hepatic acute phase proteins that are involved in the host response to infection and limit
the associated inflammatory process. Identifying the genes that regulate this hepatic
response to LPS in ruminants may provide insight into the pathogenesis of bacterial
diseases and eventually facilitate breeding of more disease resistant animals. The objective
of this research was to profile the expression of ovine hepatic genes in response to
Escherichia coli LPS challenge (0, 200, 400 ng/kg) using a bovine cDNA microarray and
quantitative real-time PCR (qRT-PCR).
Results: Twelve yearling ewes were challenged iv with E. coli LPS (0, 200, 400 ng/kg) and
liver biopsies were collected 4–5 hours post-challenge to assess hepatic gene expression
profiles by bovine cDNA microarray and qRT-PCR analyses. The expression of CD14, C3,
IL12R, NRAMP1, SOD and IGFBP3 genes was down regulated, whereas the expression of
ACTHR,  IFNαR,  CD1,  MCP-1  and  GH  was increased during LPS challenge. With the
exception of C3, qRT-PCR analysis of 7 of these genes confirmed the microarray results
and demonstrated that GAPDH is not a suitable housekeeping gene in LPS challenged
sheep.
Conclusion: We have identified several potentially important genes by bovine cDNA
microarray and qRT-PCR analyses that are differentially expressed during the ovine
hepatic response to systemic LPS challenge. Their potential role in regulating the
inflammatory response to LPS warrants further investigation.
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Background
The innate immune response to gram-negative bacterial
infections is initiated by the recognition of lipopolysac-
charide (LPS), a principal component of the cell mem-
brane that is released during bacteriolysis. During
systemic infections, LPS ligation to the hepatic Toll-like
receptor-4 complex induces the production of a wide vari-
ety of hepatic acute phase proteins that are involved in the
host response to infection and limit the associated inflam-
matory process [1]. The secretion of pro-inflammatory
cytokines for example, plays an important role in the
induction of the febrile and hypothalamic-pituitary-adre-
nal axis responses to LPS [2,3]. The liver's role in LPS
removal and metabolism is also well recognized [4], and
likely helps to protect the lungs from acute injury during
endotoxemia [5]. Given this, the identification of genes
that regulate the hepatic response to LPS in ruminants
may provide insight into the pathogenesis of bacterial dis-
eases and eventually facilitate breeding of more disease
resistant animals.
A number of studies have previously used microarrays to
study hepatic gene expression in rats, mice and dogs chal-
lenged with LPS; homologous arrays were used in these
studies [6-9]. To date however, only two ruminant micro-
array studies have been performed with bovine cells stim-
ulated with LPS, and these studies were performed in vitro
[10,11].With respect to sheep, ovine microarrays are not
currently available. However, two different groups have
constructed bovine immune-related cDNA microarrays
that hybridize with ovine cDNA [12,13]. These bovine
cDNA microarrays may therefore, be useful for assessing
ovine hepatic gene expression in response to systemic LPS
challenge.
DNA microarray technology is a powerful and frequently
used tool for studying differential gene expression. In
comparison to quantitative PCR, one of the significant
challenges presented by DNA microarray analysis is hav-
ing sufficient amounts of high quality RNA that can be
labelled and subsequently hybridized onto microarrays.
This often requires that animals be euthanized to collect
sufficient tissue for RNA extraction, which prohibits the
assessment of temporal changes in gene expression in vivo.
In this study, we amplified total RNA that was isolated
from liver biopsy samples and profiled the expression of
ovine hepatic genes in response E. coli LPS challenge (0,
200, 400 ng/kg) using bovine cDNA microarrays and
quantitative real-time PCR (qRT-PCR).
Results and discussion
Differentially expressed genes in LPS challenged animals
Gene expression analyses were performed using 8 arrays.
Statistical analysis revealed that 11 of genes on the array
were differentially expressed between the control and LPS-
treated animals (p < 0.1) (Table 1). The relative expression
of adrenocorticotropic hormone receptor (ACTHR, p <
0.07), interferon α receptor (IFNαR, p < 0.05), CD1 (p <
0.03), monocyte-chemoattractant protein 1 (MCP-1, p <
0.04) and growth hormone (GH,  p  < 0.04) genes was
increased, while complement component-3 (C3,  p  <
0.04), myeloid membrane glycoprotein (CD14, p < 0.10),
insulin-like growth factor binding protein-3 (IGFBP3, p <
0.01), interleukin 12 receptor (IL12R, p < 0.03), natural
resistance-associated macrophage protein-1 (NRAMP1, p
< 0.01) and superoxide dismutase (SOD, p < 0.08) gene
expression was decreased in the LPS-treated animals.
Overall, the fold change in gene expression for all of these
genes was low (≤ 1.49), even though the signal intensity
of MCP-1, SOD, ACTHR, IL12R and NRAMP1 was rela-
tively high (>5000 pixels) from the microarray slides.
One of the principle complications in microarray analysis
of gene expression is the relatively large amount of RNA
required for each array. On average, 5–20 µg of total RNA
are required per study. This is easily obtained from tissue
Table 1: Microarray analysis of ovine hepatic gene expression following systemic challenge with 0, 200, or 400 ng/kg LPS
Gene Description p-value Expression change
200/0
CD14 Myeloid membrane glycoprotein 0.092 -1.49
ACTHR Adrenocortropic hormone receptor 0.063 1.05
IFNaR Interferon receptor α 0.047 1.19
C3 Complement component 3 0.038 -1.28
CD1a.b.d CD1 0.026 1.22
IL12R Interleukin 12 receptor 0.021 -1.06
NRAMP1 Natural resistance associated macrophage protein 0.002 -1.04
400/0
C3 Complement component 3 0.090 -1.16
SOD Superoxide dismutase 0.071 -1.12
MCP-1 Monocyte-chemoattractant protein 1 0.035 1.05
GH Growth hormone 0.034 1.10
IGFBP3 Insulin-like growth factor binding protein 3 0.007 -1.23BMC Veterinary Research 2006, 2:34 http://www.biomedcentral.com/1746-6148/2/34
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samples collected from euthanized animals, but is more
difficult to obtain from small volume biopsy samples col-
lected from live animals. In this study, the SenseAmp kit
(Genisphere Inc. Hatfield, PA) was chosen to amplify
total RNA. Goff et al. [14] evaluated sense-strand mRNA
amplification by quantitative real-time PCR analysis.
Their results demonstrated that the SenseAmp kit yields
the highest correlation between PCR products before and
after amplification, and is also able to accurately amplify
partially degraded samples.
Validated expression of selected genes by quantitative 
real-time PCR
Validation of the microarray results by qRT-PCR was per-
formed on the CD14, IFNαR, C3, NRAMP1, SOD, MCP-1,
and IGFBP3 genes (Table 2). Two housekeeping genes,
GAPDH and RPLPO were also selected. Results from this
analysis generally support the microarray data (Figure 1).
Linear orthogonal polynomial contrasts (LOPCS) across
dose were significant for CD14 (p = 0.06), NRAMP1 (p =
0.05), SOD (p=0.07), IGFBP3 (p = 0.03), and the GAPDH
housekeeping gene (p = 0.05), indicating that the expres-
sion of these genes was reduced across LPS doses. GAPDH
has also recently been reported to not be a reliable hepatic
housekeeping gene for rats challenged with LPS [9].
LOPCS across doses was also significant for MCP-1
(p=0.02), indicating that the expression of this gene was
increased across LPS doses. A significant quadratic orthog-
onal polynomial contrast across dose was also noted for
IFNαR (p = 0.02), indicating that the highest expression of
this gene was observed at the 200 ng/kg LPS treatment
level. A significant change in the expression of C3 and the
RPLPO  housekeeping gene across LPS doses was not
observed.
The hepatic genes studied are either involved in LPS recog-
nition, or in regulating the inflammatory response that
occurs following LPS recognition. CD14 for example,
plays a key role in LPS recognition during bacterial infec-
tion. LPS ligation to CD14-TLR4 complex subsequently
activates numerous cell types to secrete pro-inflammatory
cytokines including IL-6. Recent studies performed with
bovine MAC-T cells [15], and rat lung [16] and liver tis-
sues [9] have shown that CD14 expression levels were
largely unaffected by LPS. An earlier rodent study how-
ever, reported up-regulation of CD14 3-hours, but not 6-
hours post-challenge with 4 µg/kg of LPS administered i.v
[6]. Previously, our group demonstrated that ovine CD14
gene expression increased significantly 2 hours, but not 5
hours after systemic challenge with 200 and 400 ng/kg of
LPS [17]. In the present study, CD14 gene expression was
reduced at the 5-hour sampling time. These results and
others suggest that LPS induces tissue-specific and tempo-
ral differences in CD14 gene expression.
NRAMP1 functions as a proton/divalent cation trans-
porter in the membranes of the late endosomes/lyso-
somes, regulating cytoplasmic iron levels in macrophages,
and plays a role in host innate immunity [18]. NRAMP1
gene expression is dramatically increased in murine mac-
rophages treated with LPS in vitro and in vivo [19], and its
expression is both time- and dose-dependent [20]. A study
by Wyllie et al. demonstrated using NRAMP1 knockout
mice that hepatic NRAMP1 expression is important for
inducing early phase Kupffer cell activation and hepatic
inflammation [21]. The LPS dose-dependent down regu-
lation of NRAMP1 gene expression observed in the cur-
rent study may be part of a regulatory mechanism
Table 2: Primers, and gene accession number, annealing temperature, and product size for quantitative real-time PCR analysis
Gene Forward & Reverse primer Accession no (°C) (bp)
GAPDH CCTGGAGAAACCTGCCAAGT
GCCAAATTCATTGTCGTACCA
TC186924 58 226
RPLPO CAACCCTGAAGTGCTTGACAT
AGGCAGATGGATCAGCCA
TC204704 62 220
CD14 TGAACATTGCCCAAGCACAC
GCCGAGACTGGGATTGTCAG
AY289201 58 101
C3 AGAAGCAGAAGCCTGATGGA
CCTCGCAGATGTCTTTAGCC
AF038130 60 150
IFNaR CGCATAAGAGCAGAAGAAGGA
TGTTCCAGGGGGAGAGATG
U65978 60 150
NRAMP1 TTGGCACAGCTATTGCATTC
TTCCGCAACCCGTAGTTATC
AF005380 60 121
SOD CGAGGCAAAGGGAGATACAG
TCTCCAAACTGATGGACGTG
M81129 60 90
MCP-1 GGGTGCTCATTCAGACCATT
CATGGGAACTCAAGGAGGAA
L32659 60 126
IGFBP3 CAGAGCACAGACACCCAGAA
TGCCCGTACTTATCCACACA
AF305199 58 233BMC Veterinary Research 2006, 2:34 http://www.biomedcentral.com/1746-6148/2/34
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designed to control LPS-induced inflammation in the
liver.
As a group of metal-containing enzymes, SODs have a
vital anti-oxidant role conferred by their scavenging of the
reactive oxygen species [22]. A previous study using rats
demonstrated that SOD activity decreased in the liver dur-
ing the acute phase of an in vivo LPS challenge and then
increased during the recovery phase. Similar findings were
reported with hepatocytes exposed to LPS in vitro in the
same study [23]. A microarray study using liver tissue
from rats challenged with LPS demonstrated induction of
the SOD2 gene 24 hours post LPS challenge however, no
assessment was made at earlier time points [9]. The dose-
dependent decrease in SOD  gene expression that was
observed in the present study 4–5 hours post LPS chal-
lenge, combined with these previously reported studies,
suggest that SOD gene expression varies temporally in the
liver following LPS challenge.
IGFBPs regulate the bioactivity of mitogenic IGF-I and
may also inhibit the growth of certain cell lines by an IGF-
I receptor-independent pathway [24]. Priego et al.
reported that LPS decreased the gene expression of IGFBP-
3 in the rat liver following in vivo challenge [24]. Our
results confirm their results using an ovine LPS challenge
model.
MCP-1 is an important leukocyte chemoattractant that is
involved in recruiting neutrophils and monocytes/macro-
phages during inflammation. Several studies have shown
that LPS induces MCP-1 gene expression in various tissues
Real-time PCR validation of the bovine microarray data Figure 1
Real-time PCR validation of the bovine microarray data. Values are presented as a natural loge transformed mean ± SE 
of 4 sheep per LPS dose group.BMC Veterinary Research 2006, 2:34 http://www.biomedcentral.com/1746-6148/2/34
Page 5 of 7
(page number not for citation purposes)
both in vivo and in vitro [25-27]. Two different LPS studies
performed in vivo using the rat [9] and canine models [8]
made no mention of hepatic MCP-1 induction using
microarray analysis, although another chemokine, MIP-1,
was reportedly induced 4 hours post LPS challenge in the
canine model [8]. A recent study however, reported
hepatic MCP-1 protein expression in mice challenged
with LPS [28]. Our study demonstrates that LPS also
induced hepatic MCP-1 gene expression in sheep.
All IFN subtypes are multifunctional cytokines that
exhibit differential activities through a common receptor
composed of the subunits IFNαR1 and IFNαR2 [29]. In
this study we found that the expression of IFNαR1 gene
was induced after LPS treatment, but the highest expres-
sion was observed at the 200 ng/kg LPS treatment level. A
study by Severa et al., demonstrated that human mature
dendritic cells modulate their sensitivity to IFN subtypes
by differentially regulating the IFNαR subunits [30].
Future studies on IFNαR may help us understand its role
during LPS-induced hepatic inflammation.
C3 is a key molecule in both the classical and alternative
pathways of the complement cascade. The expression of
the C3 gene appears to be dependent on LPS dose, sam-
pling time, and cell type. LPS has been reported to induce
C3 gene expression for example, in a human hepatoma
cell line in vitro [31] and in human mononuclear phago-
cytes and human polymorphonuclear leukocytes in vitro
[32,33]. Others however, have reported that C3  gene
expression is decreased in monocytes stimulated with LPS
[34], and that C3 protein expression follows a bell shaped
curve when monocytes are stimulated in vitro with LPS
between 0.1–100 ng/ml [35]. In the present study we
report that C3 expression is suppressed in the ovine liver
as determined by microarray analysis. Unfortunately,
there was insufficient power to validate these results by
qRT-PCR analysis.
Conclusion
In this study, we have identified several potentially impor-
tant genes that are differentially expressed during the
ovine inflammatory response to LPS challenge using
bovine cDNA microarray and qRT-PCR analyses. Their
potential role in regulating inflammation warrants further
investigation. A comparison of these results to those
reported in the literatures suggest that hepatic gene expres-
sion in response to LPS is dependent on multiple factors
including species, tissue, sampling time, the dose and type
of LPS.
Methods
Liver biopsy trial
Twelve yearling Riduea-Arcott ewe lambs were arbitrary
assigned to three groups and challenged with LPS (0, 200
or 400 ng/kg) from E. coli serotype 0111:B4 (Sigma
Chemical, St. Louis, MO) between 8 and 9 am. Liver biop-
sies (30–40 mg) were collected between 4 and 5 hours
post-challenge, and tissues were immediately placed in
RNAlater (Ambion, Austin, TX) and stored at -80°C until
total RNA extraction was performed. The doses and
biopsy sampling times were based on previous time trial
experiment [17].
RNA extraction and amplification
Total RNA was isolated with Trizol reagent (Invitrogen,
Burlington, ON) [17], and amplified using the Geni-
sphere's SenseAmp kit (Genisphere Inc. Hatfield, PA)
according to the manufacturer's instructions. Briefly, 0.25
µg of total RNA was used to synthesize first strand cDNA
using an oligo (dT) primer and random primer. First
strand cDNA was purified then tailed with dTTP using Ter-
minal Deoxynucleotidyl Transferase. The T4 template
Oligo was annealed to the 3' end of the cDNA. Klenow
enzyme fills in the 3'end of first strand cDNA to produce
a double-stranded T7 promoter. Sense-strand RNA (sense
RNA) copies of the original starting material were gener-
ated during in vitro transcription. Amplified sense RNA
was quantified using Agilent 2000 Bioanalyzer.
Construction of a bovine immune-endocrine cDNA 
microarray
A set of 109 immune, endocrine and inflammation-asso-
ciated genes was selected for triplicate spotting onto Corn-
ing GAPS II slides using a VIRTEK Chip Maker Pro spotter
(BioRad, Mississauga, Canada). Positive controls included
5 housekeeping genes (β-actin, GAPDH, HPRT, PRLPO
and  β2-microgobulin), and a serial dilution of pooled
bovine genomic DNA. Negative controls included a bacte-
rial gene (VapA) and a partial plasmid sequence of
pACYC177. All gene products were PCR amplified from
either bacterial clones, or liver total RNA. The original
clone sets and gene-specific primers were donated by Tao
et al. [12].
Microarray hybridization
For each sample, Alexa Fluor 555 or Alexa Fluor 647-
labeled cDNAs were generated from 2~2.5 µg of
SenseRNA using the SuperScript Indirect cDNA Labeling
system (Invitrogen, Burlington, ON). Labelled control
animal cDNA was then mixed with labeled cDNA of an
animal from either the 200, or 400 ng/kg LPS dose groups,
and then hybridized to the array for 18 h in a GeneTAC
HybStation (Genomic Solutions, Ann Arbor, MI) using
step-down temperatures from 65°C to 50°C in sealed
chambers. Following hybridization, the station applies
three washes, one with medium stringency buffer, one
with high stringency buffer and one with post wash buffer
(Genomic Solutions). Slides were finally rinsed briefly at
room temperature in 2 × SSC and once in ddH2O. WashedBMC Veterinary Research 2006, 2:34 http://www.biomedcentral.com/1746-6148/2/34
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microarrays were dried by centrifugation at 1700 rpm for
2 min in a cushioned 50 ml tube. Dye swapping was per-
formed on half of the samples to prevent dye bias. Dried
Slides were scanned using GenePix™ 4000 (Axon Instru-
ments Inc. Union City, USA). The images were analyzed
and tabulated using GenePix Pro 3.0.
Microarray data analysis
Microarray data were normalized using LOWESS (Locally
Regression and Smoothing Scatterplots) procedure of
SAS. The program was obtained from Dr. P. Coussens
(Department of Animal Science, Michigan State Univer-
sity). Normalized data were imported into Microsoft
Excel, log transformed, and the median blank intensity on
a microarray for each dye was subtracted from the respec-
tive normalized spot intensity values. These blank cor-
rected values were then used to calculate a mean log
expression difference between LPS-treated and control
samples. The significance of the values was determined
using a two-tailed Student's t-test. The antilog of the mean
log expression difference for an individual gene on the
array yielded the approximate fold change in expression
between cDNA from the LPS-dose groups and control
group.
Quantitative real-time PCR and analysis
To confirm gene expression differences observed from
microarray results, qRT-PCR was performed on 9 genes.
The primers for housekeeping gene, GAPDH and RPLPO
were developed by Tellam [36]. Other primers were devel-
oped using Primer 3 software by our group (Table 2).
qRT-PCR was performed in triplicate for each sample on
ABI 7000 Sequence detection system (Applied Biosys-
tems, Streetsville, ON) using default two-step amplifica-
tion procedures and 2 × SYBR Green Master Mix
(Invitrogen, Burlington, ON) in a 25 µl reaction volume
according to manufacture instructions. The conditions for
the PCR reaction were: 50°C for 2 min, 95°C for 2 min
followed by a maximum of 50 cycles of 95°C for 15 sec,
annealing temperature for 30 sec and 72°C for 30 sec. The
annealing temperatures for genes of interest are included
in Table 2. The standard curve method was used to deter-
mine relative quantitation of mRNA abundance [37]. Sta-
tistical analysis was carried out on the qRT-PCR data using
GLM of SAS (SAS 2002, SAS Institute Inc., Gary, NC).
Orthogonal polynomial contrasts were performed on the
least squares means to identify both linear and quadratic
responses across dose. Residual plots were examined to
assess homogeneity of variance.
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